In 2010, two small molecule inhibitors of Wnt/beta-catenin/LEF1 signalling (CGP049090 and PKF115-584) significantly inhibited the proliferation of CLL cells in vivo [60]. Here, CTNNB1 is linked to B-cell chronic lymphocytic leukemia.